Analysts think PAVM stock price could increase by 664%
Aug 01, 2024, 6:26 AM
2.50%
What does PAVM do
PAVmed Inc., a multi-product, commercial-stage medical technology company based in New York City, operates in Medical Devices, Diagnostics, and Digital Health, and went public in 2016. Key subsidiaries include Lucid Diagnostics for cancer prevention diagnostics, marketing EsoGuard and EsoCheck, and Veris Health, which focuses on personalized cancer care through remote monitoring technologies.
6 analysts think PAVM stock price will increase by 663.56%. The current median analyst target is $6.63 compared to a current stock price of $0.87. The lowest analysts target is $4.04 and the highest analyst target is $23.10.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.